CYBB and endothelial dysfunction: These studies demonstrated that VAS2870 by inhibiting NOX2 and ROS production, can restore epithelium barrier integrity in LPS-induced human alveolar epithelial cells [114], and endothelial dysfunction in insulin-treated human adipose microvascular endothelial cell (HAMECs) [115].